Embolx
- Company typePrivate
- Founded2013
- HeadquartersSunnyvale, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Embolx firmographics
Firmographics- Name
- Embolx
- Legal name
- Embolx, Inc.
- Website
- https://embolx.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Embolx industry classification
Industry- Product category
- Interventional Radiology Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)
- akta.pro secondary industry
- Infusion Sets, Catheters & Pump Consumables (HLAHAIAH)
Keywords
Where Embolx is headquartered
LocationHeadquarters
- HQ city
- Sunnyvale
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Embolx business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Medical Device Hardware Sales: Embolx generates revenue through the sale of proprietary balloon occlusion microcatheters (Sniper and Soldier product families) and related medical devices. The company sells directly to hospitals, interventional radiology departments, and through international distribution partners.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Embolx product offering
Product offeringCore offering
Embolx manufactures and sells proprietary balloon occlusion microcatheters—principally the Sniper® Balloon Occlusion Microcatheter (including its G3 third-generation variant) and the Soldier® High Flow Microcatheter—used by interventional radiologists for pressure-directed arterial embolization procedures to treat cancerous tumors, benign prostatic hyperplasia (PAE), and uterine fibroids. The devices are sold to hospitals, academic medical centers, VA healthcare, and international distributors under FDA 510(k) and CE Mark clearances.
Product overview
Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures. The product portfolio consists of two core product lines: the Sniper® Balloon Occlusion Microcatheter (including its G3 third-generation variant) and the Soldier® High Flow Microcatheter. The Sniper products set a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues. The company is committed to improving treatment of cancerous tumors, benign prostatic hyperplasia, and uterine fibroids through minimally invasive procedures.
Differentiator
Problem solved
Functional benefit
Brands
- Sniper: Sniper Balloon Occlusion Microcatheter - FDA-cleared device for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues.
- Soldier
Products and services
- Sniper® Balloon Occlusion Microcatheter FDA-cleared balloon occlusion microcatheter designed for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues. Features straight tip and K-tip variants with working lengths from 110–165 cm, outer diameter 2.9F proximal/2.2F distal, balloon diameter up to 6 mm, and injection pressure up to 900 psi. Used by interventional radiologists for tumor embolization (B-TACE, Y-90 radioembolization), prostate artery embolization (PAE), uterine fibroid embolization, and other peripheral embolization procedures.
- Sniper G3 Balloon Occlusion Microcatheter Third generation Sniper Balloon Occlusion Microcatheter featuring 24-month shelf life, improved trackability, enhanced efficiency, ease of use, and streamlined preparation for targeted embolization procedures, built on the same pressure-directed embolization platform as the prior Sniper generation.
- Soldier® High Flow Microcatheter FDA-cleared high-flow microcatheter designed for easy navigation through small complex vascular structures providing enhanced reach to distal target sites. Available in 2.0F and 2.5F sizes and compatible with Lipiodol, glue (n-BCA), coils up to 0.018", gelfoam, spherical particles up to 900 μm, DMSO, and ethanol. Used by interventional radiologists for peripheral embolization procedures including uterine fibroid embolization, AVM, renal AML, and gastrointestinal bleeds.
Quantifiable outcome
- Clinical data from >1,000 patients supporting balloon occlusion embolization efficacy
- +2 more outcomes
Companies that use Embolx
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles4 records
Embolx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Embolx partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and major.
- VariancoreAgreement between Embolx and Varian paves the way for advanced image-guided therapies for cancer. This strategic partnership combines Embolx's balloon occlusion microcatheter technology with Varian's image-guided radiation therapy capabilities for integrated cancer treatment solutions.
- Girlow USAcoreEmbolx Inc and Girlow USA joined forces to expand distribution into South America, extending market reach beyond existing distribution networks.
- CardivacoreEmbolx signed international distribution agreement with Cardiva for global distribution of Sniper and Soldier microcatheter products.
- U.S. Department of Veterans AffairsmajorEmbolx signed agreement with the U.S. Department of Veterans Affairs for Sniper Balloon Occlusion Microcatheter supply, enabling VA hospitals to access the technology for veteran healthcare.
Scale indicators3 records
Recent moves7 records
Expansion highlights6 records
Embolx competitors and assessment
Company assessmentBroad incumbents
- Terumo Medical: Terumo's Progreat microcatheter is widely used in embolization procedures globally, making Terumo a broad incumbent competitor in the same interventional radiology and oncology catheter category.
- Medtronic: Medtronic offers a broad interventional portfolio that includes embolization and microcatheter solutions as part of its wider peripheral vascular and oncology businesses, making it an indirect but highly resourced competitor.
Direct peers
- Merit Medical Systems: Merit's Cantata and Maestro microcatheters compete directly in embolization procedures for oncology, UFE and GI bleeds, overlapping the same interventional radiology call point and indications that Embolx targets with Sniper and Soldier.
- AngioDynamics: AngioDynamics sells the NanoKnife and embolization-related oncology and IR products, directly overlapping Embolx's interventional oncology and Y-90 workflow targets.
- Cook Medical: Cook Medical supplies embolization microcatheters and coils used in tumor, UFE and AVM procedures, positioning it as a direct competitor in the same procedural catheter segment Embolx serves.
- Penumbra: Penumbra's Indigo and Ruby peripheral embolization portfolios compete with Embolx in the high-flow microcatheter and plug-based embolization space for tumor and vascular procedures.
- Boston Scientific: Boston Scientific markets the Direxion and Renegade HI-FLO microcatheter families used in tumor and peripheral embolization, making it the most direct head-to-head competitor to Embolx's Sniper and Soldier in interventional radiology accounts.
Emerging players
- Guerbet: Guerbet supplies Lipiodol and other interventional radiology contrast/drug-delivery products central to TACE procedures, positioning it as an adjacent and complementary competitor in Embolx's core oncology embolization workflow.
- Sirtex Medical: Sirtex is focused on Y-90 radioembolization for liver cancer, overlapping Embolx's Y-90/B-TACE use cases where Sniper balloon-occlusion is positioned to enhance targeted delivery.
Others
- Cardiva (Distributor): Cardiva is Embolx's international distribution partner signed in 2023 for global rollout of Sniper and Soldier, and is comparable as an adjacent channel player in interventional radiology device distribution rather than as a product competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Embolx social profiles
Digital presenceEmbolx financial estimates
Financial estimateRevenue estimate
Valuation estimate
Embolx leadership team
Management profileNumber of profiles
Profiles9 records
Embolx funding detail
Funding detailFunding overview
Funding rounds6 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Embolx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Embolx
What does Embolx do?
Embolx manufactures and sells proprietary balloon occlusion microcatheters—principally the Sniper® Balloon Occlusion Microcatheter (including its G3 third-generation variant) and the Soldier® High Flow Microcatheter—used by interventional radiologists for pressure-directed arterial embolization procedures to treat cancerous tumors, benign prostatic hyperplasia (PAE), and uterine fibroids. The devices are sold to hospitals, academic medical centers, VA healthcare, and international distributors under FDA 510(k) and CE Mark clearances.
Is Embolx a public or private company?
Embolx is a private company. It is classified as venture growth investor backed and is currently operating.
When was Embolx founded?
Embolx was founded in 2013. It employs 1 to 10 people.
Where is Embolx based?
Embolx is headquartered in Sunnyvale, United States, in the North America region.
How does Embolx make money?
One revenue line is on record: medical Device Hardware Sales.
Who are Embolx's main competitors?
Broad incumbents on record are Terumo Medical and Medtronic. Direct peers are Merit Medical Systems, AngioDynamics, Cook Medical, Penumbra and Boston Scientific. Emerging players are Guerbet and Sirtex Medical. Cardiva (Distributor) is listed as an others.
Does Embolx have an API?
No public API is recorded for Embolx.
What industry is Embolx in?
Embolx's product category is Interventional Radiology Medical Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices, with a secondary code of HLAHAIAH, Infusion Sets, Catheters & Pump Consumables. Its NAICS code is 339112 and its SIC code is 3841.